Pharmanutra S.p.A.

€74.40As of Sun 8 Nov 2026, 12:00 UTC
BIT:PHNHealthcare
Country Italy
PE (Fwd) •••
TSR 9Y CAGR 22.57%
Div yield 1.61%
ROE 31.60%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.20
PE TTM 34.36
TSR TTM 63.18%
Mkt cap €712.4M
ROIC 29.78%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€78
5.50%
593.36%
Hold 9|9|6|12|11
4Q25
1Q26
2Q26
3Q26
Earnings per share€
1.68
1.70
1.67
1.69
5.86%
9.11%
7.68%
0.73%
Revenue€M
31.22
32.63
33.18
33.76
1.60%
7.42%
7.23%
10.03%
Peers (US$799.9M)
Cap (US$)
PE
12.25B
22.38x
955.8M
3.800x
Capital
TTM
5Y
10Y
Leveragex
3.712
0.064
0.061
EBIT/Intx
1.188
0.376
0.379
Own earn%
(42.65)
264.20
225.38
Sh yield%
27.13
25.37
26.20
Owners
Insiders/Inst%
4.07
83.29
Short interest%
2.42
SBC / revenue%
3.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
2–14
$1 testx
—
Incr. ROIC%
6